Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/02/1989 | WO1989010409A1 Bone and cartilage inductive compositions |
11/02/1989 | WO1989010405A1 Chimeric glycoproteins containig immunogenic segments of human parainfluenza virus type 3 |
11/02/1989 | WO1989010403A1 Human gm-csf variants |
11/02/1989 | WO1989010374A1 Aprotinin analogues and a process for the production thereof |
11/02/1989 | WO1989010133A1 Stem cell inhibitors |
11/02/1989 | WO1989007651A3 Methods for controlling norleucine content in polypeptides |
11/02/1989 | EP0340170A2 Process for the production of polypeptides |
11/02/1989 | EP0340109A2 Anti-T-cell receptor determinants as autoimmune disease treatment |
11/02/1989 | EP0340002A1 A human-human hybridoma derived monoclonal antibody, and the use thereof |
11/02/1989 | EP0339982A1 Antibiotic compounds |
11/02/1989 | EP0339942A2 Aprotinin analogues and process for the production thereof |
11/02/1989 | EP0339814A1 Reagent for measuring creatine kinase activity and measuring method thereof |
11/02/1989 | EP0339686A1 Nucleic acid hybridization assay |
11/02/1989 | EP0339633A2 Anti-human gastric cancer monoclonal antibody |
11/02/1989 | EP0339632A2 Method of assaying human cancer antigens |
11/02/1989 | EP0339569A2 Expression of the HIV 24 KDA GAG protein in methylotrophic yeasts |
11/02/1989 | EP0339568A1 Expression of Human Interleukin-2 in Methylotrophic Yeasts |
11/02/1989 | EP0339567A1 Expression of Hepatitis B PreS 2 Protein in Methylotrophic Yeasts |
11/02/1989 | EP0339505A2 Monoclonal antibodies to tissue plasminogen activator (t-PA) which prolong its functional half-life |
11/02/1989 | EP0339504A2 Human immunodeficiency virus (HIV) env-coded peptide capable of eliciting HIV-inhibiting antibodies in mammals |
11/02/1989 | EP0339443A2 Monoclonal antibody for the selective immune determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids |
11/02/1989 | EP0339285A2 Recombinant endonexin II |
11/02/1989 | EP0339163A2 Monoclonal antibodies specific for HIV and hybridomas for their production |
11/01/1989 | CN1036795A 肽衍生物 Peptide derivatives |
11/01/1989 | CN1036794A Process for increasing yield of cytokins |
11/01/1989 | CN1036793A Monoclonal antibody specific to mucin-like glycoprotein surface antigen on human carcinoma cells |
10/31/1989 | US4877615 Antifungal product |
10/31/1989 | CA1262533A1 High level production of swine growth hormone |
10/31/1989 | CA1262532A1 Composition useful for the production of vaccines containing particles with the surface antigen of the hepatitis b virus and the receptor of the polymerized human serum albumin, animal cells capable of producing such particles and process for their obtention |
10/25/1989 | EP0338846A2 Monoclonal antibodies |
10/25/1989 | EP0338807A2 Production of isolated proteinaceous materials using recombinant avipox virus vectors |
10/25/1989 | EP0338767A2 Novel recombinant and chimeric antibodies directed against a human adenocarcinoma antigen |
10/25/1989 | EP0338745A1 Method for producing recombinant DNA proteins |
10/25/1989 | EP0338716A2 Method and system for the production of non-degraded proteins from mammalian cells |
10/25/1989 | EP0338634A2 Viper venom polypeptides and genetic expression |
10/25/1989 | EP0338620A1 Recovery of hepatitis B surface antigen |
10/25/1989 | EP0338566A2 Pertussis toxoid vaccine |
10/25/1989 | EP0338497A2 Bispecific hybrid monoclonal antibody |
10/25/1989 | EP0338436A2 Monoclonal antibody against neuropeptide Y, method for its preparation as well as its use |
10/25/1989 | EP0338395A2 Monoclonal antibodies to Pseudomonas aeruginosa, their production and use |
10/25/1989 | EP0338266A2 Artificial chromosome vector |
10/25/1989 | EP0338265A2 Haemophilus influenzae type B polysaccharide-outer membrane protein conjugate vaccine |
10/25/1989 | EP0338170A1 Immunoprotective antigenic protein against pathogenic bacteria |
10/25/1989 | EP0338169A1 Method for obtaining protective antigens against bordetella infections and toxic processes |
10/25/1989 | EP0259455A4 Nephritis strain associated protein. |
10/25/1989 | EP0192657B1 Monoclonal antibody directed to human ganglioside gd 2? |
10/24/1989 | US4876242 Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast |
10/24/1989 | US4876194 Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain |
10/19/1989 | WO1989009834A1 Calcium channel compositions and methods |
10/19/1989 | WO1989009831A1 Lak cell cytotoxin |
10/19/1989 | WO1989009829A2 Methods of generating desired amino-terminal residues in proteins |
10/19/1989 | WO1989009828A1 Method and materials for the microbial bioconversion of toluene and other phenyl compounds |
10/19/1989 | WO1989009825A1 Method for producing recombinant dna proteins |
10/19/1989 | WO1989009819A1 Combining mutations for stabilization of subtilisin |
10/19/1989 | WO1989009817A1 Composition and method for acceleration of clot lysis |
10/19/1989 | WO1989009792A1 Method for potentiating and inhibiting insulin-like growth factor activity |
10/19/1989 | WO1989009791A1 Dna encoding androgen receptor protein |
10/19/1989 | WO1989009790A1 Monoclonal antibody to enteroviruses |
10/19/1989 | WO1989009789A1 Human monoclonal antibodies against rabies virus |
10/19/1989 | WO1989009788A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
10/19/1989 | WO1989009787A2 Osteogenic devices |
10/19/1989 | WO1989009785A1 Peptides inhibitors of hiv induced cell fusions and syncytia formation |
10/19/1989 | WO1989009622A1 Il-2 receptor-specific chimeric antibodies |
10/19/1989 | WO1989009621A2 Compounds for diagnosis and/or therapy of tumours |
10/19/1989 | WO1989009605A1 Bone-inducing protein |
10/19/1989 | WO1989009227A3 Pf10 to pf19 peptides of an hiv retrovirus, process for synthetizing said peptides and their use, in particular for diagnosis |
10/19/1989 | DE3910323A1 Biologically active proteins |
10/18/1989 | EP0337799A2 14-Beta-gal mammalian lectins |
10/18/1989 | EP0337731A2 Peptide antibiotics |
10/18/1989 | EP0337707A2 Method for purification of polyglutamate |
10/18/1989 | EP0337589A2 Recombinant and native group B eimeria tenella immunogens useful as coccidiosis vaccines |
10/18/1989 | EP0337586A2 Identification of NK cells and cytotoxic T lymphocytes |
10/18/1989 | EP0337532A1 Recombinant DNA; transformed microorganisms, plant cells and plants; a process for introducing an inducible property in plants, and a process for producing a polypeptide or protein by means of plants or plant cells |
10/18/1989 | EP0337492A1 Purification of hepatitis proteins |
10/18/1989 | EP0337430A2 Antitumor antibiotic kedarcidin |
10/18/1989 | EP0337359A2 Lymphokine production and purification |
10/18/1989 | EP0337264A2 Method for the production of proteins beginning their N-terminus with proline |
10/18/1989 | EP0337243A1 Process for purifying recombinant human interleukin-2 |
10/18/1989 | EP0337057A1 Method to identify the origin of a cell or tissue sample |
10/18/1989 | CN1036407A Preparation of disease-resistant active substance from tussah chrysalis and method of its purification |
10/17/1989 | US4874697 Protease deficient mutant; producing protein or polypeptide with increased interferon activity |
10/11/1989 | EP0336760A2 Bone-inducing protein |
10/11/1989 | EP0336736A1 Purification of pertussis toxins and production of vaccine |
10/11/1989 | EP0336719A2 Method and materials for the microbial bioconversion of toluene and other phenyl compounds |
10/11/1989 | EP0336693A2 Acceleration of clot lysis |
10/11/1989 | EP0336677A1 A method for early detection of lung cancer |
10/11/1989 | EP0336454A1 Nucleic acid hybridization assay |
10/11/1989 | EP0336441A2 Anti-CPBII monoclonal antibody |
10/11/1989 | EP0336413A1 A novel system of inducible positive regulation of use for production of heterologous proteins |
10/11/1989 | EP0336405A2 Anti-human cancer protein complexes, their production and use |
10/11/1989 | EP0336379A2 Antibody heteroconjugates for use in regulation of lymphocyte activity |
10/11/1989 | EP0336324A1 Process for treating insoluble fused heterogenic protein |
10/11/1989 | EP0336230A2 Cyclic peptide antagonists of Substance P and Substance K |
10/11/1989 | EP0336155A1 Recombinant human cardiac myosin |
10/11/1989 | EP0335949A1 Paired helical filament core and antibody thereto useful in diagnosing alzheimer's disease |
10/11/1989 | EP0335900A1 Human interleukin-4 muteins |
10/10/1989 | US4873359 Process for preparing as partyl-phenylalanine dipeptides |
10/10/1989 | US4873316 Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
10/10/1989 | US4873312 Unfolding in denaturing solution; diafiltration |
10/10/1989 | US4873190 Heterodimeric T lymphocyte receptor |